Fosun Pharma USA Inc. established in 2017, is a subsidiary of a leading global healthcare group, Fosun Pharma (SSE: 600196) (SEHK:2196) and Fosun International Limited (SEHK: 656), a leading conglomerate and investment company.
Innovation, research and development, excellence in quality, supply reliability and patient affordability are core driving factors of Fosun Pharma USA. Based in Princeton, New Jersey, Fosun Pharma USA markets specialty injectables, develops partnerships to bring late-stage assets to the U.S. and China markets, and seeks investment opportunities with cutting-edge healthcare technologies through FUSION, our drug discovery incubator.
Our company embodies an entrepreneurial spirit dedicated to improving the lives of patients and their families through innovative, accessible and affordable healthcare. With global manufacturing capabilities, Fosun Pharma USA remains agile to changes in the market and open to opportunities in several therapeutic categories for both branded and generic products.
Superior quality and reliable supply of cost-effective generic injectables
Partnerships to in-license or acquire innovative and generic products
Fosun Pharma US Innovation Hub (FUSION) invests in early-stage portfolio companies